Advertisement
UK markets open in 19 minutes

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,737.73
    +453.19 (+2.62%)
     

  • CRUDE OIL

    84.02
    +0.45 (+0.54%)
     

  • GOLD FUTURES

    2,350.50
    +8.00 (+0.34%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • Bitcoin GBP

    51,403.84
    +65.74 (+0.13%)
     

  • CMC Crypto 200

    1,391.17
    -5.37 (-0.38%)
     

  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     

  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Global Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Analysis

Research and Markets
·7-min read

Dublin, March 16, 2021 (GLOBE NEWSWIRE) -- The "Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Treatment Type; Route of Administration; End User and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the global malaria treatment market was valued at US$ 1,508.12 million in 2019 and is projected to reach US$ 2,126.42 million by 2027; it is expected to grow at a CAGR of 4.4% from 2020 to 2027. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Based on treatment type, the malaria treatment market is segmented into vaccine, diagnostic test, and antimalarial agents. The diagnostic test segment held the largest share of the market in 2019. The growth of this segment is ascribed to the demand for high-quality and cost-efficient diagnostic methods, and introduction of novel diagnostic techniques. Also, the governments in the Middle East and Africa are taking measures to help the patients, such as Sanofi's digitization steps to control malaria through MOSKI kit awareness in children in malaria endemic countries are being successful in the malaria treatment market.

The growth of the malaria treatment market is attributed to the high prevalence of malaria in low-income countries, and increasing initiatives undertaken by governments globally. However, increasing resistance to antimalarial drugs hinders the growth of this market. Advanz Pharmaceutical, Ipca Laboratories Ltd, Zydus Cadila, Glenmark, Olympus Corporation, Abbott, Sun Pharmaceutical Industries Ltd, Sanofi, GlaxoSmithKline plc., Novartis AG, and TEVA PHARMACEUTICAL INDUSTRIES LTD are among the leading companies operating in the global malaria treatment market.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the malaria treatment market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Malaria Treatment Market - By Treatment Type
1.3.2 Global Malaria Treatment Market - By Route of Administration
1.3.3 Global Malaria Treatment Market - By End User
1.3.4 Global Malaria Treatment Market - By Geography

2. Malaria Treatment Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Malaria treatment- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinions

5. Global Malaria Treatment Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 High Prevalence of Malaria in Low-Income Countries
5.1.2 Increasing Initiatives Undertaken by Governments Globally
5.2 Key Market Restraints
5.2.1 Increasing Resistance to Antimalarial Drugs
5.3 Key Market Opportunities
5.3.1 Increasing Research for New Drugs and Vaccines
5.4 Future Trends
5.4.1 Rapid Diagnostic Tests for Malaria

6. Malaria Treatment Market - Global Analysis
6.1 Global Malaria treatment Market Revenue Forecast And Analysis
6.2 Global Malaria treatment Market, By Geography - Forecast And Analysis
6.3 Market Positioning

7. Malaria treatment Market Analysis - By Treatment Type
7.1 Overview
7.2 Malaria treatment Market Revenue Share, by Treatment Type (2019 and 2027)
7.4 Vaccine
7.4.1 Overview
7.4.2 Vaccine: Malaria treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Antimalarial Agents
7.5.1 Overview
7.5.2 Antimalarial Agents: Malaria treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Diagnostic Test
7.6.1 Overview
7.6.2 Diagnostic Test: Malaria treatment Market - Revenue and Forecast to 2027 (US$ Million)

8. Malaria treatment Market Analysis - By Route of Administration
8.1 Overview
8.2 Malaria treatment Market Revenue Share, by Route of Administration (2019 and 2027)
8.4 Oral
8.4.1 Overview
8.4.2 Oral: Malaria treatment Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Parenteral
8.5.1 Overview
8.5.2 Parenteral: Malaria treatment Market - Revenue and Forecast to 2027 (US$ Million)

9. Malaria treatment Market Analysis - By End User
9.1 Overview
9.2 Malaria treatment Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Malaria treatment Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Malaria treatment Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Malaria treatment Market - Revenue and Forecast to 2027 (US$ Million)

10. Malaria Treatment Market - Geographical Analysis
10.1 North America: Malaria Treatment Market
10.2 Europe: Malaria Treatment Market
10.3 Asia Pacific: Malaria Treatment Market
10.4 Middle East & Africa: Malaria Treatment Market
10.5 South and Central America: Malaria Treatment Market

11. Impact of COVID-19 Pandemic on Global Malaria Treatment Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 MEA: Impact Assessment of COVID-19 Pandemic
11.5 SACM: Impact Assessment of COVID-19 Pandemic

12. Malaria Treatment Market- Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 Advanz Pharmaceutical
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Ipca Laboratories Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Zydus Cadila
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Glenmark
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Olympus Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Abbott
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sun Pharmaceutical Industries Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Sanofi
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 GlaxoSmithKline plc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Novartis AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/czz4wi

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900